AR113724A1 - Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda o el síndrome de la mancha blanca, que incluye bacillus subtilis - Google Patents
Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda o el síndrome de la mancha blanca, que incluye bacillus subtilisInfo
- Publication number
- AR113724A1 AR113724A1 ARP180103904A ARP180103904A AR113724A1 AR 113724 A1 AR113724 A1 AR 113724A1 AR P180103904 A ARP180103904 A AR P180103904A AR P180103904 A ARP180103904 A AR P180103904A AR 113724 A1 AR113724 A1 AR 113724A1
- Authority
- AR
- Argentina
- Prior art keywords
- food composition
- bacillus subtilis
- white spot
- spot syndrome
- necrosis disease
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 244000063299 Bacillus subtilis Species 0.000 title abstract 3
- 235000014469 Bacillus subtilis Nutrition 0.000 title abstract 3
- 230000001154 acute effect Effects 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 230000017074 necrotic cell death Effects 0.000 title abstract 3
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 206010028851 Necrosis Diseases 0.000 abstract 2
- 241000696962 White spot syndrome virus Species 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 241000238557 Decapoda Species 0.000 abstract 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente se refiere a una composición alimenticia para la prevención o el tratamiento de la enfermedad de necrosis hepatopancreática aguda (AHPND) o el síndrome de la mancha blanca (WSS), que comprende una cepa de Bacillus subtilis (KCCM11143P), un medio de cultivo de la misma, un concentrado de la misma o un material seco de la misma como un componente activo. La composición alimenticia muestra actividad antibacteriana contra Vibrio parahaemolyticus que provoca AHPND de camarón y actividad antiviral contra el virus del síndrome de la mancha blanca (WSSV) que provoca WSS. Reivindicación 1: Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda (AHPND), que comprende una cepa de Bacillus subtilis, medios de cultivo de las mismas; sus concentrados; o sus materias secas como principio activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170184265 | 2017-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR113724A1 true AR113724A1 (es) | 2020-06-03 |
Family
ID=67261354
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180103905A AR113725A1 (es) | 2017-12-29 | 2018-12-28 | Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda (ahpnd) o el síndrome de la mancha blanca (wss), que comprende una cepa de bacillus subtilis, una cepa de bacillus pumilus y una cepa de bacillus licheniformis como principios activos |
ARP180103904A AR113724A1 (es) | 2017-12-29 | 2018-12-28 | Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda o el síndrome de la mancha blanca, que incluye bacillus subtilis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180103905A AR113725A1 (es) | 2017-12-29 | 2018-12-28 | Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda (ahpnd) o el síndrome de la mancha blanca (wss), que comprende una cepa de bacillus subtilis, una cepa de bacillus pumilus y una cepa de bacillus licheniformis como principios activos |
Country Status (13)
Country | Link |
---|---|
US (2) | US11432566B2 (es) |
EP (2) | EP3530123A4 (es) |
JP (3) | JP6898989B2 (es) |
KR (2) | KR102277987B1 (es) |
CN (2) | CN110602950A (es) |
AR (2) | AR113725A1 (es) |
AU (2) | AU2018395021A1 (es) |
BR (2) | BR112019007616B1 (es) |
CL (3) | CL2019001463A1 (es) |
CO (2) | CO2020009486A2 (es) |
EC (2) | ECSP20044931A (es) |
PH (2) | PH12019500838A1 (es) |
TW (2) | TWI693894B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102277987B1 (ko) * | 2017-12-29 | 2021-07-16 | 씨제이제일제당 주식회사 | 바실러스 서브틸리스 균주, 바실러스 푸밀러스 균주 및 바실러스 리체니포미스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물 |
KR102154172B1 (ko) * | 2019-03-28 | 2020-09-10 | 전한택 | 흰반점증후군바이러스 및 비브리오 세균의 갑각류 감염을 억제하는 생균제 및 그의 용도 |
KR102255611B1 (ko) | 2019-10-14 | 2021-05-24 | 염상구 | 복합 균주를 이용한 완전배합 발효사료의 제조방법 |
CN111165652A (zh) * | 2020-01-19 | 2020-05-19 | 博益德(北京)生物科技有限公司 | 一种河蟹用发酵饲料及其制备方法与应用 |
CN112753629B (zh) * | 2020-12-30 | 2022-08-30 | 亚太海洋生物科技(厦门)有限公司 | 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法 |
KR102669096B1 (ko) * | 2022-03-30 | 2024-05-24 | 국립군산대학교 산학협력단 | 신규한 아스로박터 부세이 smg 균주 및 이를 포함하는 새우용 사료 조성물 |
JP2024097592A (ja) * | 2023-01-06 | 2024-07-19 | 住友化学株式会社 | エビ目の生物におけるウイルス感染症に対する予防または治療用経口投与組成物 |
CN117844673A (zh) * | 2023-11-18 | 2024-04-09 | 江苏省海洋水产研究所 | 一种拮抗副溶血性弧菌的枯草芽孢杆菌jshy-k3及复合制剂和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824106B1 (ko) * | 2006-05-30 | 2008-04-21 | 주식회사 씨티씨바이오 | 흰반점바이러스를 치료 또는 예방하기 위한 조성물 및 방법 |
KR20080061582A (ko) * | 2006-12-28 | 2008-07-03 | 부경대학교 산학협력단 | 흰반점 바이러스 항원 유전자의 재조합 단백질 생성 및발현방법과 이를 이용한 면역증강 사료첨가제 |
KR100977407B1 (ko) | 2008-02-26 | 2010-08-24 | 대한민국 | 비특이 면역증강 효능이 있는 자이고사카로마이세스 바일리용균추출물 |
KR20110035554A (ko) | 2009-09-30 | 2011-04-06 | 전남대학교산학협력단 | 바실러스 속 cmb l1 및 락토바실러스 속 cmb 201의 혼합균주 및 이를 이용한 항암 및 면역증강용 식품 조성물 |
KR101242821B1 (ko) * | 2011-01-31 | 2013-03-12 | 씨제이제일제당 (주) | 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스 |
KR101230813B1 (ko) | 2011-01-31 | 2013-02-06 | 씨제이제일제당 (주) | 사프로레그니아 속 미생물에 대한 생물학적 방제용 프로바이오틱스 |
KR20130047329A (ko) * | 2011-10-31 | 2013-05-08 | 대한뉴팜(주) | 바실러스 서브틸리스 np15 균주를 포함하는 사료첨가용 조성물 |
KR101370943B1 (ko) * | 2012-04-05 | 2014-03-12 | 씨제이제일제당 (주) | 신규 분리한 바실러스 리체니포미스 및 이를 이용한 프로바이오틱스 |
US20150216915A1 (en) | 2012-04-12 | 2015-08-06 | Dupont Nutrition Biosciences Aps | Microbial Strains and Their Use in Animals |
CN102895677B (zh) * | 2012-10-30 | 2014-03-12 | 无锡海健生物科技有限公司 | 一种新型对虾多价载体疫苗及其应用 |
CN103301409B (zh) | 2013-07-04 | 2015-01-21 | 宜春强微生物科技有限公司 | 防治虾偷死病的组合物及其制备方法 |
CN104195068A (zh) * | 2014-07-25 | 2014-12-10 | 青岛尚德生物技术有限公司 | 一种用于预防和治疗对虾早期死亡综合症的复合微生态制剂及其应用 |
CN104388338B (zh) * | 2014-10-27 | 2015-06-24 | 中国水产科学研究院黄海水产研究所 | 一种复合菌制剂及其应用 |
CN104312961A (zh) * | 2014-10-27 | 2015-01-28 | 中国水产科学研究院黄海水产研究所 | 一种枯草芽孢杆菌菌株及其应用 |
WO2016073981A1 (en) * | 2014-11-07 | 2016-05-12 | BiOWiSH Technologies, Inc. | Antibacterial compositions and methods of use |
KR101738591B1 (ko) * | 2015-02-06 | 2017-05-24 | 한국해양자원연구소 주식회사 어업회사법인 | 갑각류 양식용 미생물 제재 및 이를 이용한 갑각류의 생산성 증진방법 |
CN104664164A (zh) * | 2015-03-11 | 2015-06-03 | 任芳芳 | 一种可降低南美白对虾白斑综合征病毒病害的饲料添加剂 |
WO2017031371A1 (en) * | 2015-08-20 | 2017-02-23 | Api Holdings, Llc | Formulations and methods for promoting honeybee health |
US20190002819A1 (en) * | 2015-12-28 | 2019-01-03 | Novozymes Bioag A/S | Heat priming of bacterial spores |
WO2017147130A2 (en) * | 2016-02-23 | 2017-08-31 | Novozymes A/S | Direct fed microbial for prevention of shrimp disease |
KR102277987B1 (ko) | 2017-12-29 | 2021-07-16 | 씨제이제일제당 주식회사 | 바실러스 서브틸리스 균주, 바실러스 푸밀러스 균주 및 바실러스 리체니포미스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물 |
-
2018
- 2018-12-27 KR KR1020180171280A patent/KR102277987B1/ko active IP Right Grant
- 2018-12-27 KR KR1020180171279A patent/KR20190082122A/ko not_active IP Right Cessation
- 2018-12-28 BR BR112019007616-6A patent/BR112019007616B1/pt active IP Right Grant
- 2018-12-28 CN CN201880004734.3A patent/CN110602950A/zh active Pending
- 2018-12-28 JP JP2019520990A patent/JP6898989B2/ja active Active
- 2018-12-28 US US16/349,838 patent/US11432566B2/en active Active
- 2018-12-28 CN CN201880004885.9A patent/CN110278704A/zh active Pending
- 2018-12-28 EP EP18859983.1A patent/EP3530123A4/en not_active Withdrawn
- 2018-12-28 TW TW107147913A patent/TWI693894B/zh active
- 2018-12-28 JP JP2019521083A patent/JP6812545B2/ja active Active
- 2018-12-28 AU AU2018395021A patent/AU2018395021A1/en not_active Abandoned
- 2018-12-28 AU AU2018395016A patent/AU2018395016B2/en active Active
- 2018-12-28 AR ARP180103905A patent/AR113725A1/es active IP Right Grant
- 2018-12-28 AR ARP180103904A patent/AR113724A1/es active IP Right Grant
- 2018-12-28 EP EP18859986.4A patent/EP3530124A4/en active Pending
- 2018-12-28 TW TW107147914A patent/TWI722358B/zh active
- 2018-12-28 US US16/461,348 patent/US20200315211A1/en not_active Abandoned
- 2018-12-28 BR BR112019007636-0A patent/BR112019007636B1/pt active IP Right Grant
-
2019
- 2019-04-16 PH PH12019500838A patent/PH12019500838A1/en unknown
- 2019-05-16 PH PH12019501100A patent/PH12019501100A1/en unknown
- 2019-05-30 CL CL2019001463A patent/CL2019001463A1/es unknown
- 2019-05-30 CL CL2019001464A patent/CL2019001464A1/es unknown
-
2020
- 2020-07-29 EC ECSENADI202044931A patent/ECSP20044931A/es unknown
- 2020-07-29 EC ECSENADI202044912A patent/ECSP20044912A/es unknown
- 2020-07-29 CO CONC2020/0009486A patent/CO2020009486A2/es unknown
- 2020-07-29 CO CONC2020/0009472A patent/CO2020009472A2/es unknown
- 2020-12-11 CL CL2020003225A patent/CL2020003225A1/es unknown
-
2021
- 2021-02-26 JP JP2021030743A patent/JP7036964B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR113724A1 (es) | Una composición de alimento para prevenir o tratar la enfermedad de necrosis hepatopancreática aguda o el síndrome de la mancha blanca, que incluye bacillus subtilis | |
CL2016001811A1 (es) | Compuestos heterociclos derivados de 3-(azepan-1-il-sulfonil)-n-fenilbenzamida; composición farmacéutica, útiles para tratar y prevenir la infección por vhb | |
BR112017011923A2 (pt) | bactéria modificada para tratar doenças associadas com hiperamonemia | |
CO2019009215A2 (es) | Sal hemi-sulfato de nucleótido para el tratamiento del virus de la hepatitis c | |
ECSP10010618A (es) | Análogos carba - nucleósidos para tratamiento antiviral | |
CL2011002852A1 (es) | Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias. | |
MX2017000307A (es) | Tratamiento de leucemia con inhibidores de histona deacetilasa. | |
HK1143738A1 (en) | Ido inhibitors ido | |
BR112013026494A2 (pt) | composto, composição farmacêutica, método para tratar condição | |
CL2017001822A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
BR112017022768A2 (pt) | desinfecção de tecido com ondas de choque de pressão acústica | |
CO2018004684A2 (es) | Métodos para tratar la epilepsia | |
UY32715A (es) | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados | |
CO2021002691A2 (es) | Composiciones y métodos para editar el gen hidroxiácido oxidasa 1 (hao1) para tratar la hiperoxaluria primaria tipo 1 (ph1) | |
AR123345A1 (es) | Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus | |
MX2019004029A (es) | Compuestos y metodos para diagnosis y tratamiento de infecciones virales. | |
EA201790383A1 (ru) | Композиции и способы лечения и профилактики инфекций области хирургического вмешательства | |
UY32720A (es) | Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados | |
CL2017002846A1 (es) | Métodos de tratamiento de trastornos linfoproliferativos asociados al virus de epstein-barr por terapia con células t. | |
CL2020001888A1 (es) | Terapia de combinación para tratar o prevenir el cáncer. | |
BR112018002548A2 (pt) | composição antimicrobiana com eficácia contra endoesporos | |
MX2016012536A (es) | Rnasa para su uso en el tratamiento o la prevencion de infecciones virales. | |
BR112017028190A2 (pt) | Peptídeo, peptídeo peguilado, composição, composição farmacêutica, frasco, solução de desinfecção, método para inibição de crescimento, replicação ou infectividade de um micro- organismo, método para inibição de crescimento bacteriano, método para inibição de replicação viral em uma célula, método para tratamento de uma infecção de micro-organismo em um sujeito e prevenção de uma doença em um sujeito causada por ou associada a uma infecção de micro- organismo, método para inibição de crescimento bacteriano em um sujeito, método para tratamento de uma infecção bacteriana em um sujeito e tratamento de uma doença causada por ou associada a uma infecção bacteriana, método para prevenção de uma doença causada por ou associada a uma infecção bacteriana em um sujeito, método para inibição de replicação viral em um sujeito, método para tratamento de uma infecção viral em um sujeito e tratamento de uma doença causada por ou associada a uma infecção viral em um sujeito, método para prevenção de uma doença causada por ou associada a uma infecção viral em um sujeito, método para desinfecção de um objeto inanimado ou material biológico e superfície inanimada ou superfície biológica | |
MX2021004215A (es) | Combinaciones de inhibidores de la replicación del virus de la gripe. | |
CO6660456A2 (es) | Agente preventivo o terpéutico contra la fibrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |